$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax

$dvax Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000119312513315086 Filed on August 01, 2013

Income Statement

Concept	2013 Q3	2013 Q2	2012 Q2
Revenue	$2.927M	$3.392M	$2.684M
YoY Change	1.84%	26.38%	-63.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.730M	$7.640M	$5.960M
YoY Change	-5.48%	28.19%	47.16%
% of Gross Profit
Research & Development	$11.77M	$12.81M	$11.38M
YoY Change	-8.4%	12.56%	-14.19%
% of Gross Profit
Depreciation & Amortization	$340.0K	$330.0K	$300.0K
YoY Change	9.68%	10.0%	-23.08%
% of Gross Profit
Operating Expenses	$11.77M	$12.81M	$11.38M
YoY Change	-8.4%	12.56%	-14.19%
Operating Profit	-$15.57M	-$17.05M	-$14.65M
YoY Change	-8.94%	16.38%	45.1%
Interest Expense	$24.00K	$27.00K	$589.0K
YoY Change	-95.93%	-95.42%	20.94%
% of Operating Profit
Other Income/Expense, Net	-$120.0K	-$142.0K	$63.00K
YoY Change	-38.78%	-325.4%	-184.0%
Pretax Income	-$15.68M	-$17.16M	-$15.11M
YoY Change	-11.86%	13.57%	42.01%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$15.68M	-$17.16M	-$15.11M
YoY Change	-11.89%	13.59%	42.08%
Net Earnings / Revenue	-535.53%	-506.01%	-562.97%
Basic Earnings Per Share
Diluted Earnings Per Share	-$856.8K	-$938.2K	-$789.4K
COMMON SHARES
Basic Shares Outstanding	183.0M shares	182.9M shares	156.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q3	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$76.50M	$89.20M	$160.2M
YoY Change	-48.42%	-44.32%	159.64%
Cash & Equivalents	$12.19M	$17.59M	$34.53M
Short-Term Investments	$64.30M	$71.60M	$125.7M
Other Short-Term Assets	$1.100M	$1.200M	$4.100M
YoY Change	-54.17%	-70.73%	127.78%
Inventory
Prepaid Expenses
Receivables	$2.159M	$2.025M	$1.284M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$79.75M	$92.43M	$165.6M
YoY Change	-48.34%	-44.2%	155.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.454M	$8.038M	$6.833M
YoY Change	21.68%	17.64%	3.53%
Goodwill	$2.532M	$2.436M	$2.356M
YoY Change	5.15%	3.4%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.0K	$463.0K	$438.0K
YoY Change	-31.05%	5.71%	-51.33%
Total Long-Term Assets	$11.95M	$11.59M	$10.27M
YoY Change	14.43%	12.84%	5.85%
TOTAL ASSETS
Total Short-Term Assets	$79.75M	$92.43M	$165.6M
Total Long-Term Assets	$11.95M	$11.59M	$10.27M
Total Assets	$91.70M	$104.0M	$175.9M
YoY Change	-44.37%	-40.87%	136.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.289M	$1.253M	$1.155M
YoY Change	-18.31%	8.48%	-32.06%
Accrued Expenses	$8.148M	$7.307M	$7.340M
YoY Change	-11.08%	-0.45%	3.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$13.90M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.56M	$14.91M	$25.26M
YoY Change	-47.0%	-40.99%	145.23%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$988.0K	$627.0K	$616.0K
YoY Change	58.33%	1.79%	-90.38%
Total Long-Term Liabilities	$988.0K	$627.0K	$616.0K
YoY Change	58.33%	1.79%	-96.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.56M	$14.91M	$25.26M
Total Long-Term Liabilities	$988.0K	$627.0K	$616.0K
Total Liabilities	$19.30M	$19.35M	$25.88M
YoY Change	-44.48%	-25.21%	-9.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$489.2M	-$473.5M	-$397.2M
YoY Change	17.88%	19.22%
Common Stock	$183.0K	$183.0K	$178.0K
YoY Change	2.81%	2.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$72.40M	$84.66M	$144.7M
YoY Change
Total Liabilities & Shareholders Equity	$91.70M	$104.0M	$175.9M
YoY Change	-44.37%	-40.87%	136.42%

Cashflow Statement

Concept	2013 Q3	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$15.68M	-$17.16M	-$15.11M
YoY Change	-11.89%	13.59%	42.08%
Depreciation, Depletion And Amortization	$340.0K	$330.0K	$300.0K
YoY Change	9.68%	10.0%	-23.08%
Cash From Operating Activities	-$12.25M	-$15.69M	-$15.69M
YoY Change	-0.81%	0.0%	63.1%
INVESTING ACTIVITIES
Capital Expenditures	-$490.0K	-$290.0K	-$470.0K
YoY Change	48.48%	-38.3%	67.86%
Acquisitions
YoY Change
Other Investing Activities	$7.150M	$8.490M	-$38.91M
YoY Change	303.95%	-121.82%	1606.58%
Cash From Investing Activities	$6.660M	$8.210M	-$39.38M
YoY Change	362.5%	-120.85%	1438.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.00K	20.00K	70.04M
YoY Change	-92.47%	-99.97%	275.35%
NET CHANGE
Cash From Operating Activities	-12.25M	-15.69M	-15.69M
Cash From Investing Activities	6.660M	8.210M	-39.38M
Cash From Financing Activities	70.00K	20.00K	70.04M
Net Change In Cash	-5.520M	-7.460M	14.97M
YoY Change	-44.69%	-149.83%	131.02%
FREE CASH FLOW
Cash From Operating Activities	-$12.25M	-$15.69M	-$15.69M
Capital Expenditures	-$490.0K	-$290.0K	-$470.0K
Free Cash Flow	-$11.76M	-$15.40M	-$15.22M
YoY Change	-2.16%	1.18%	62.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	182987918	shares
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34530000
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	182988000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2025000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	17542000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8038000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	71572000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	92427000
CY2013Q2	dvax	Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice	3.19
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17585000
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	263000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	263000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6800000
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	71576000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	17543000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10503000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17622000	shares
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.37
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.20
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	16754000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	182988000	shares
CY2013Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3820000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14906000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-810000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	3680000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-814000
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	558766000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	13896000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1253000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1114000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2301000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	627000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	84659000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-473480000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6346000
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7307000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2201000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2350000
CY2013Q2	us-gaap	Liabilities Liabilities	19353000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2250000
CY2013Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	600000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	183000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104012000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	463000
CY2013Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	71576000
CY2013Q2	us-gaap	Goodwill Goodwill	2436000
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	89157000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	54029000
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	648000
CY2012Q4	dvax	Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice	3.38
CY2012Q4	dvax	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	46000
CY2012Q4	dvax	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1000
CY2013Q2	us-gaap	Assets Assets	104012000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	263000
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	89161000
CY2013Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	89200000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1241000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	54034000
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	182792000	shares
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5283000
	dei	Trading Symbol TradingSymbol	DVAX
	dei	Entity Registrant Name EntityRegistrantName	DYNAVAX TECHNOLOGIES CORP
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2013Q2	dvax	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	13000
CY2013Q2	dvax	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	9000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31941000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	182792000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13806000	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19014000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-595000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-640000
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	550729000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2166000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	629000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	114826000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-435491000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6785000
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10063000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	45000
CY2012Q4	us-gaap	Liabilities Liabilities	24926000
CY2012Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	600000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	183000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139752000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	473000
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	117531000
CY2012Q4	us-gaap	Goodwill Goodwill	2475000
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	125085000
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	652000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1005000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7965000
CY2012Q4	us-gaap	Assets Assets	139752000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7599000
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	125130000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2052000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	128187000
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001029142
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5421000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	182934000	shares
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	900000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y5M16D
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-30000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1902000
	us-gaap	Interest Expense InterestExpense	59000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-913000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2758000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34575000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M13D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	74000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates and assumptions.</font></p> </div>
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.41
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35000
	us-gaap	Share Based Compensation ShareBasedCompensation	8002000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	646000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9986000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	828000
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1083000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-41000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	126000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	29527000
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-41000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-128000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-811000
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	5300000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-174000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1020000
	us-gaap	Revenues Revenues	5477000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38204000
	us-gaap	Contracts Revenue ContractsRevenue	2239000
	us-gaap	Revenue From Grants RevenueFromGrants	2155000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37928000
	us-gaap	Net Income Loss NetIncomeLoss	-37989000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-530000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-215000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	147000
	us-gaap	Costs And Expenses CostsAndExpenses	43405000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16436000
	us-gaap	Share Based Compensation ShareBasedCompensation	4391000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	592000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2589000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-113000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2425000
	us-gaap	Interest Expense InterestExpense	1176000
	dvax	Reclassification Adjustments From Accumulated Other Comprehensive Income ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome	0
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-638000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-238000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	128000
	us-gaap	Costs And Expenses CostsAndExpenses	35531000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	74911000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3900000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44556000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26969000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-885000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-820000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1095000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	70085000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45718000
	dvax	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	-142000
	dvax	Proceeds From Stock Options And Restricted Shares Exercised ProceedsFromStockOptionsAndRestrictedSharesExercised	30000
	dvax	Increase Decrease In Restricted Cash And Other Assets For Operating Activities IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities	-14000
	dvax	Supplemental Disposal Of Assets SupplementalDisposalOfAssets	8000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	161564000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23870000
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1403000
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	513000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-27000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	117000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	114400000
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-27000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3015000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-211000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8243000
	us-gaap	Revenues Revenues	5034000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31853000
	us-gaap	Contracts Revenue ContractsRevenue	2552000
	us-gaap	Revenue From Grants RevenueFromGrants	1969000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30497000
	us-gaap	Net Income Loss NetIncomeLoss	-31615000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23781000
	dvax	Reclassification Adjustments From Accumulated Other Comprehensive Income ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome	0
	dvax	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	70819000
	dvax	Proceeds From Stock Options And Restricted Shares Exercised ProceedsFromStockOptionsAndRestrictedSharesExercised	1343000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11750000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72290000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-640000
CY2012Q2	us-gaap	Revenues Revenues	2684000
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15777000
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-33000
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	54000
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-142000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	173000
CY2013Q2	us-gaap	Revenues Revenues	3392000
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17024000
CY2013Q2	us-gaap	Contracts Revenue ContractsRevenue	1356000
	dvax	Increase Decrease In Restricted Cash And Other Assets For Operating Activities IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities	69000
	dvax	Supplemental Disposal Of Assets SupplementalDisposalOfAssets	19000
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	167697000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	39300000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2012Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	179000
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-27000
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	65000
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	63000
CY2012Q2	us-gaap	Contracts Revenue ContractsRevenue	1623000
CY2012Q2	us-gaap	Revenue From Grants RevenueFromGrants	882000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-14649000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-15110000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-667000
CY2012Q2	us-gaap	Costs And Expenses CostsAndExpenses	17333000
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5957000
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2069000
CY2012Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000
CY2012Q2	us-gaap	Interest Expense InterestExpense	589000
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11376000
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	182913000	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31700000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	641000
CY2013Q2	us-gaap	Revenue From Grants RevenueFromGrants	1395000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17049000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-17164000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	140000
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	20441000
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7636000
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3736000
CY2013Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000
CY2013Q2	us-gaap	Interest Expense InterestExpense	27000
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12805000

Files In Submission

Name	View Source	Status
0001193125-13-315086-index-headers.html	Edgar Link	pending
0001193125-13-315086-index.html	Edgar Link	pending
0001193125-13-315086.txt	Edgar Link	pending
0001193125-13-315086-xbrl.zip	Edgar Link	pending
d546739d10q.htm	Edgar Link	pending
d546739dex311.htm	Edgar Link	pending
d546739dex312.htm	Edgar Link	pending
d546739dex321.htm	Edgar Link	pending
d546739dex322.htm	Edgar Link	pending
dvax-20130630.xml	Edgar Link	completed
dvax-20130630.xsd	Edgar Link	pending
dvax-20130630_cal.xml	Edgar Link	unprocessable
dvax-20130630_def.xml	Edgar Link	unprocessable
dvax-20130630_lab.xml	Edgar Link	unprocessable
dvax-20130630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax

2013 Q3 Form 10-Q Financial Statement

#000119312513315086 Filed on August 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVAX DYNAVAX TECHNOLOGIES CORP Stock $dvax

2013 Q3 Form 10-Q Financial Statement

#000119312513315086 Filed on August 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax